Xylocaine 2%

Valsts: Jaunzēlande

Valoda: angļu

Klimata pārmaiņas: Medsafe (Medicines Safety Authority)

Aktīvā sastāvdaļa:

Lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg Lignocaine hydrochloride anhydrous; Lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous; Lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous; Lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous

Pieejams no:

Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics

SNN (starptautisko nepatentēto nosaukumu):

Lidocaine hydrochloride monohydrate 21.3 mg (= 20 mg Lignocaine hydrochloride anhydrous)

Deva:

2 %

Zāļu forma:

Solution for injection

Kompozīcija:

Active: Lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg Lignocaine hydrochloride anhydrous Excipient: Hydrochloric acid as 2M solution for pH adjustment to pH 6.7-6.8 Methyl hydroxybenzoate Sodium chloride Sodium hydroxide as 2M solution for pH adjustment to pH 6.7-.68 Water for injection Active: Lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous Excipient: Sodium chloride Sodium hydroxide as 2M solution for pH adjustment Water for injection Active: Lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous Excipient: Sodium chloride Sodium hydroxide as 2M solution for pH adjustment Water for injection Active: Lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous Excipient: Hydrochloric acid Sodium chloride Sodium hydroxide as 2M solution for pH adjustment Water for injection

Vienības iepakojumā:

Polyamp, 20mL, 5 dose units

Klase:

Prescription

Receptes veids:

Prescription

Ražojis:

Cambrex Karlskoga AB

Ārstēšanas norādes:

XYLOCAINE solutions are indicated for the production of local or regional anaesthesia by the following techniques: - local infiltration - minor or major nerve blocks - epidural block - arthroscopy - intravenous regional anaesthesia

Produktu pārskats:

Package - Contents - Shelf Life: Polyamp, 20mL - 5 dose units - 36 months from date of manufacture stored at or below 30°C - Polyamp, 5mL - 50 dose units - 36 months from date of manufacture stored at or below 25°C - Polyamp, 2mL - 50 dose units - 18 months from date of manufacture stored at or below 25°C - Syringe, Pre-filled, 5mL - 10 dose units - 24 months from date of manufacture stored at or below 30°C - Syringe, Pre-filled, 2mL - 10 dose units - 24 months from date of manufacture stored at or below 30°C - Vial, glass, multi-dose, 50mL - 5 dose units - 36 months from date of manufacture stored at or below 25°C - Vial, glass, multi-dose, 20mL - 5 dose units - 36 months from date of manufacture stored at or below 25°C

Autorizācija datums:

1969-12-31

Produkta apraksts

X
YLOCAINE
Data Sheet
NEW ZEALAND DATA SHEET
1. PRODUCT NAME
Xylocaine 1% Solution for Injection
Xylocaine 2% Solution for Injection
Xylocaine 1% with Adrenaline 1:100,000 Solution for Injection
Xylocaine 1% with Adrenaline 1:200,000 Solution for Injection
Xylocaine 2% with Adrenaline 1:200,000 Solution for Injection
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Xylocaine 1%: Each mL of solution for injection contains 10mg of
lidocaine hydrochloride.
Xylocaine 2%: Each mL of solution for injection contains 20mg of
lidocaine hydrochloride.
Xylocaine 1% with Adrenaline 1:100,000: Each mL of solution for
injection contains 10mg of
lidocaine hydrochloride and 10micrograms of adrenaline (epinephrine)
as acid tartrate.
Xylocaine 1% with Adrenaline 1:200,000: Each mL of solution for
injection contains 10mg of
lidocaine hydrochloride and 5micrograms of adrenaline (epinephrine) as
acid tartrate.
Xylocaine 2% with Adrenaline 1:200,000: Each mL of solution for
injection contains 20mg of
lidocaine hydrochloride and 5micrograms of adrenaline (epinephrine) as
acid tartrate.
(Note: Lidocaine is another name for lignocaine. Lidocaine is used in
this document.
Epinephrine is another name for adrenaline. Adrenaline is mostly used
in this document.)
For full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
X
YLOCAINE
solution for injection is a sterile, isotonic aqueous solution. The pH
of the solution
is 5.0-7.0. The ampoules are free from preservatives and are intended
for single use only.
X
YLOCAINE
with adrenaline solution for injection is a sterile, isotonic aqueous
solution. It
contains sodium metabisulphite as an antioxidant. The pH of the
solution is 3.3-5.0.
4. CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
X
YLOCAINE
solutions are indicated for the production of local or regional
anaesthesia by the
following techniques:
•
local infiltration
•
minor or major nerve blocks
•
epidural block
•
arthroscopy
•
intravenous regional anaesthesia
X
YLOCAINE
Data Sheet
Copyright
2
4.2
DOSE AND METHOD OF ADMINISTRA